Overview

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Cytos Biotechnology AG